awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34659512-0F95777F-2E99-434E-A6D6-43A071751B35
Q34659512-0F95777F-2E99-434E-A6D6-43A071751B35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34659512-0F95777F-2E99-434E-A6D6-43A071751B35
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3
P2860
Q34659512-0F95777F-2E99-434E-A6D6-43A071751B35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34659512-0F95777F-2E99-434E-A6D6-43A071751B35
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33277bc576bae2755c2e6d005826fd780fcaa068
P2860
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancer.